What is Paclitaxel?
Category: Prescription Drugs
Most popular types: Taxol Abraxane
See also: Doxorubicin-cyclophosphamide-paclitaxel (ACT) Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab (AC-TH) Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab-pertuzumab (AC-THP) Gemcitabine-paclitaxel Paclitaxel-bevacizumab Paclitaxel-trastuzumab-carboplatin Paclitaxel-trastuzumab-pertuzumab (THP) Paclitaxel-trastuzumab (TH)
Paclitaxel is an anticancer drug used in the treatment of breast, nonsmall cell lung, and ovarian cancers; and AIDS-related Kaposi's sarcoma. It has also been used for bladder, cervical, small cell lung, and head and neck cancers.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Ovarian cancer | 271 | 5 | |
| Endometrial cancer | 28 | 5 | |
| Breast cancer | 12 | 4 | |
| Stomach cancer | 9 | 0 | |
| Lung cancer | 4 | 3 | |
| Squamous cell carcinoma (non-small cell lung cancer) | 3 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 5 | |
| Moderate | 7 | |
| Mild | 8 | |
| None | 1 |
Commonly reported side effects and conditions associated with Paclitaxel
| Side effect | Patients | Percentage |
|---|---|---|
| Hair loss | 7 | |
| Fatigue | 5 | |
| Diarrhea | 2 | |
| Breathing difficulty | 1 | |
| Chest tightness | 1 | |
| Eyebrow thinning | 1 |
Duration
Stopped taking Paclitaxel
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 2 | |
| 1 - 6 months | 15 | |
| 6 months - 1 year | 2 | |
| 2 - 5 years | 1 |
What people switch to and from
Patients started taking Paclitaxel after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Cyclophosphamide (Cytoxan) | 1 | |
| Pemetrexed (Alimta) | 1 | |
| Pertuzumab (Perjeta) | 1 | |
| Trastuzumab (Herceptin) | 1 |
Patients stopped taking Paclitaxel and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Abemaciclib (Verzenio) | 1 | |
| Bevacizumab (Avastin) | 1 | |
| Eribulin (Halaven) | 1 | |
| Lenvatinib (Lenvima) | 1 | |
| Nivolumab (Opdivo) | 1 |
Last updated: